Preoperative Stress Assessment in Patients Undergoing Surgery for Rotator Cuff Tendinopathy
Condition(s) studied
Investigational drug(s) / intervention(s)
Questionnaires: MSP9 score Cungi scale EVA scale
Study summary
Orthopedic surgery of the limbs presents a unpredictable postoperative course, which can be more or less lengthy in terms of functional recovery and resumption of personal or professional activities. Not uncommon, convalescence can require many months with dramatic personal and/or socio-professional consequences (disability, unemployment, etc.), particularly in the postoperative development of complex regional pain syndrome (CRPS) and/or adhesive capsulitis.
Among the suspected contributing factors, the existence of an unfavorable preoperative psychological context in patients is often mentioned.
This research is based on the hypothesis that a high level of preoperative stress in patients could contribute to the occurrence of more significant postoperative complications in patients who have undergone shoulder surgery.
The main objective is to measure the level of preoperative stress in patients undergoing surgery for rotator cuff tendinopathy.
Eligibility
Primary outcome measure(s)
- Stress will be assessed using the MSP9 score. — Preoperation
This score ranges from 9 to 72 based on a rating scale of 1 to 8 (reversed for positive items): * 9-26 - Very low stress level * 27-44 - Low stress level * 45-54 - Moderate stress level * 55-63 - High stress level * 64-72 - Very high stress level
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Clinique des Cèdres | Cornebarrieu | France | Recruiting |
| Clinique la croix du sud | Quint-Fonsegrives | France | Recruiting |
| Clinique de l'Union | Saint-Jean | France | Recruiting |
More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07658326 on ClinicalTrials.gov ↗ ← All trials in France